http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-186736-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9afcd0369d6402247555a4656c0917 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-70 |
| filingDate | 1980-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f622dd8ee6a05b0b1487a34626ce961d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a268f914010294f0eb12ef2d34bfa2bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2793b8829f97364edda06fd5770b615f |
| publicationDate | 1985-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-186736-B |
| titleOfInvention | Process for producing new 4-aroylimidazol2-one derivatives |
| abstract | A compound for the alleviation of hypotension or the treatment of cardiac failure, having the formula <IMAGE> wherein R is hydrogen, C1-4 alkyl, (C1-4 alkyl) carbonyl or benzoyl; R1 is hydrogen or C1-4 alkyl; and Ar is 2-furyl; 2-thienyl; phenyl; phenyl monosubstituted by halogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, trifluoromethyl, -SO2N(R2)2, NR3R4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkylpiperazino in which R2, R3 and R4 are independently selected from hydrogen and C1-4 alkyl; disubstituted phenyl in which one substituent is at the para position and the substituents are independently selected from halogen, hydroxy, C1-4 alkyl and C1-4 alkoxy; or 3,4-methylenedioxy- phenyl in which the methylene group is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof. Many compounds of formula I are novel. |
| priorityDate | 1979-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.